The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
The present study analyzes the importance of the inflammasome that involves the NLRP3 complex in the state of hypercytokinemia observed in patients with COVID-19, significantly increasing IL-1β, IL18, IL-6, and TNF. Unfortunately, improving the immune response can sometimes worsen the outcome of the...
Main Authors: | Sandro Augusto Ribeiro, Cassio Lopes, Ricardo Amaral, Adilaine Amaral |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Metabolism Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936820300256 |
Similar Items
-
Cytokine storm and colchicine potential role fighting SARS-CoV-2 pneumonia
by: Antonio Vitiello, et al.
Published: (2020-04-01) -
Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis
by: Chi-Hone Lien, et al.
Published: (2021-08-01) -
Possible ameliorative effect of colchicine on the prevention of cytokine storm and its associated hyper-inflammation in patients with COVID-19
by: Bijan Keikhaei, et al.
Published: (2020-01-01) -
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01) -
Colchicine Overdose in a Suicidal Attempt
by: Fatemeh Eghbali, et al.
Published: (2019-10-01)